{
    "Trade/Device Name(s)": [
        "Steroid 21-Hydroxylase Antibody (21-OHAb) RIA Assay",
        "KRONUS 21-Hydroxylase Antibody (21-OHAb) RIA Assay Kit",
        "KRONUS Steroid 21-OHAb RIA Assay"
    ],
    "Submitter Information": "KRONUS Market Development Associates Inc.",
    "510(k) Number": "k121046",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCG"
    ],
    "Summary Letter Date": "December 18, 2012",
    "Summary Letter Received Date": "December 19, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibody immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Steroid 21-hydroxylase antibody (21-OHAb)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Radioimmunoassay (RIA)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for KRONUS Steroid 21-Hydroxylase Antibody RIA Assay for the semiquantitative detection of 21-OH antibodies in human serum.",
    "Indications for Use Summary": "Semiquantitative determination of antibodies to steroid 21-hydroxylase in human serum to aid in the diagnosis of autoimmune adrenal disease, including autoimmune Addison's disease and autoimmune polyglandular syndrome, used alongside other clinical and laboratory findings.",
    "fda_folder": "Immunology"
}